COLL News and Press, Collegium Pharmaceutical Inc. From 11/10/19

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 130 weeks of public selections as part of this ongoing live forward-testing. In...

Shares of Collegium Pharmaceutical (NASDAQ: COLL) were soaring 33.7% higher as of 11:12 a.m. EST on Thursday. This big jump came following the small drugmaker's third-quarter update after the market closed on Wednesday. Collegium missed Wall Street estimates on both its top and bottom lines...

Collegium Pharmaceuticals ( COLL +30.9% ) is up on more than a 4x surge in volume in early trade in reaction to its Q3 results released after the close yesterday. Highlights: More news on: Collegium Pharmaceutical, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on t...

Collegium Pharmaceutical, Inc. (COLL) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joseph Ciaffoni - President and Chief Executive Officer Paul Brannelly - Chief Financial Officer Scott Dreyer - Chie...

Image source: The Motley Fool. Collegium Pharmaceutical Inc   (NASDAQ: COLL) Q3 2019 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading

Collegium Pharmaceutical (NASDAQ: COLL ): Q3 GAAP EPS of -$0.18 misses by $0.03 . More news on: Collegium Pharmaceutical, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

– New Exclusive Formulary Wins Announced for Xtampza ® ER Effective January 1, 2020 Covering More than 35 Million Lives – – Xtampza ® ER Net Product Revenues Were $26.5 Million in the Third Quarter of 2019, a 56% Increase Over the Third Quarter of 2018 ...

STOUGHTON, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, November 6, 2019 at 4:30 p.m. Eastern Time. The Company will discuss its financial results an...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 125 weeks of public selections as part of this ongoing live forward-testing. In...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 120 weeks of public selections as part of this ongoing live forward-testing. In...